You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Details for Patent: 6,423,340


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,423,340
Title: Method for the treatment of inflammatory bowel diseases
Abstract:Described herein are methods comprising the oral administration of budesonide for the treatment of ulcerative colitis and Crohn's colitis in its active phase. The methods can also be applied as relapse preventing therapy for Crohn's colitis in its chronic phase and Crohn's disease in the small intestine.
Inventor(s): Ulmius; Jan (Lund, SE)
Assignee: Aktiebolaget Draco (Sodertalje, SE)
Application Number:09/159,301
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;

Drugs Protected by US Patent 6,423,340

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,423,340

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8903914Nov 15, 1990
PCT Information
PCT FiledNovember 15, 1990PCT Application Number:PCT/SE90/00738
PCT Publication Date:May 30, 1991PCT Publication Number: WO91/07172

International Family Members for US Patent 6,423,340

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 125445 ⤷  Try a Trial
Australia 643021 ⤷  Try a Trial
Australia 7786491 ⤷  Try a Trial
Canada 2071518 ⤷  Try a Trial
Germany 502092 ⤷  Try a Trial
Germany 69021214 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.